Table 3.
—Medications by Class
| Medication | Overall (N = 110) | Insomnia (n = 28) | Comorbid (n = 42) | OSA (n = 27) | Control Subjects (n= 13) | χ2 | P Value |
| Currently on medications | 41 (37.3) | 12 (42.9) | 21 (50.0)a,b | 6 (22.2)a | 2 (15.4)b | 8.56 | < .05 |
| NBDRA | 6 (5.5) | 2 (7.1) | 3 (7.1) | 1 (3.7) | 0 (0.0) | 1.30 | .730 |
| Antidepressants | 30 (27.3) | 8 (28.6)a | 18 (42.9)b | 2 (7.4)a,b | 2 (15.4) | 11.47 | < .01 |
| Atypical antipsychotics | 2 (1.8) | 1 (3.6) | 1 (2.4) | 0 (0.0) | 0 (0.0) | 1.30 | .730 |
| Benzodiazepines | 4 (3.6) | 3 (10.7) | 0 (0.0) | 1 (3.7) | 0 (0.0) | 6.08 | .108 |
| Narcotics | 18 (16.4) | 6 (21.4) | 9 (21.4) | 3 (11.1) | 0 (0.0) | 4.40 | .221 |
| Prazosin | 6 (5.5) | 2 (7.1) | 4 (9.5) | 0 (0.0) | 0 (0.0) | 3.81 | .283 |
Data are presented as No. (%) unless otherwise indicated. NBDRA = nonbenzodiazepine receptor agonist. See Table 1 legend for expansion of other abbreviation.
a,b
Groups with the same letter(s) represent significant differences as tested by χ2 analysis.